Current Pharmaceutical Biotechnology
Title:Preeclampsia – Aetiopathogenesis and Clinical Management
Volume: 19 Issue: 10
Author(s): Marzena Laskowska*
Affiliation:
- Chair and Department of Obstetrics and Perinatology, II Faculty of Medicine with English Language Division Medical University of Lublin Lublin,Poland
Export Options
About this article
Cite this article as:
Laskowska Marzena *, Preeclampsia – Aetiopathogenesis and Clinical Management, Current Pharmaceutical Biotechnology 2018; 19 (10) . https://dx.doi.org/10.2174/138920101910181112114656
DOI https://dx.doi.org/10.2174/138920101910181112114656 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment
Current Drug Targets Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry AMPK - Activated Protein Kinase and its Role in Energy Metabolism of the Heart
Current Cardiology Reviews Applications of Circadian Metabolomics
Current Metabolomics Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Implications for Endothelium-Derived Hyperpolarizing Factor (EDHF) in Womens Cardiovascular Health
Current Women`s Health Reviews The Effect of Risk Factor Changes on Peripheral Arterial Disease and Cardiovascular Risk
Current Drug Targets - Cardiovascular & Hematological Disorders The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
Current Pharmaceutical Design Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Current Neuropharmacology Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Mental Health Patients at High Risk for Obesity, Type 2 Diabetes, and Cardiovascular Disease: An Australian Perspective
Current Hypertension Reviews Lithium and Kidney, 60 Years Later
Current Drug Safety Cellular and Physiological Effects of Ganoderma lucidum (Reishi)
Mini-Reviews in Medicinal Chemistry Liraglutide Therapy in a Prediabetic State: Rethinking the Evidence
Current Diabetes Reviews Diagnosis, Treatment, and New Developments in Preeclampsia
Current Women`s Health Reviews Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders-Drug Targets Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Medicinal Chemistry Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Current Vascular Pharmacology Cytochrome P450 2C8 and Drug Metabolism
Current Topics in Medicinal Chemistry Relaxin in Vascular Physiology and Pathophysiology: Possible Implications in Ischemic Brain Disease
Current Neurovascular Research